34122672|t|Evidence-based traditional Siddha formulations for prophylaxis and management of respiratory symptoms in COVID-19 pandemic-a review.
34122672|a|The recent outbreak of COVID-19 is attributed to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). This viral disease is rapidly spreading across the globe, including India. The mainstay in managing the disease is supportive care, nutrition, and preventing further progression in the absence of proven antiviral drugs. Currently two vaccines Covishield and Covaxin are administered in India. Long-term plans of developing most reliable mRNA-based vaccines are also underway for the future method of prophylaxis. The Siddha system of medicine's holistic approach emphasizes lifestyle modification, prophylactic interventions, and dietary management to boost the host immunity and treatment with herbal medicines and higher-order medicines as the case may be. In this review, a brief outline of the disease COVID-19, Coronavirus, evidence-based traditional Siddha interventions for respiratory ailments and immune boosters highlighting the relevant published research on individual herbs are dealt, which pave way for further research on drug repurposing for COVID-19. Historical evidence on the prevention and treatment of infections especially antivirals in Siddha classics is studied.
34122672	81	101	respiratory symptoms	Disease	MESH:D012818
34122672	105	113	COVID-19	Disease	MESH:D000086382
34122672	156	164	COVID-19	Disease	MESH:D000086382
34122672	182	229	Severe Acute Respiratory Syndrome Coronavirus 2	Species	2697049
34122672	231	241	SARS-CoV-2	Species	2697049
34122672	502	509	Covaxin	Disease	
34122672	950	958	COVID-19	Disease	MESH:D000086382
34122672	960	971	Coronavirus	Disease	MESH:D018352
34122672	1025	1045	respiratory ailments	Disease	MESH:D012131
34122672	1202	1210	COVID-19	Disease	MESH:D000086382
34122672	1267	1277	infections	Disease	MESH:D007239

